We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
320 hedge funds and large institutions have $1.68B invested in Ginkgo Bioworks in 2022 Q4 according to their latest regulatory filings, with 88 funds opening new positions, 119 increasing their positions, 57 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
109% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 57
105% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 43
67% more call options, than puts
Call options by funds: $11.4M | Put options by funds: $6.83M
15% more funds holding
Funds holding: 278 → 320 (+42)
0.02% more ownership
Funds ownership: 1.84% → 1.86% (+0.02%)
39% less capital invested
Capital invested by funds: $2.74B → $1.68B (-$1.06B)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
320
Holders Change
+42
Holders Change %
+15.11%
% of All Funds
5.14%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
88
Increased
119
Reduced
57
Closed
43
Calls
$11.4M
Puts
$6.83M
Net Calls
+$4.61M
Net Calls Change
-$11.3M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$92.2M |
| 2 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
+$56.2M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$40.4M |
| 4 |
BlackRock
New York
|
+$36.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$89.1M |
| 2 |
NSGL
No Street GP LP
San Francisco,
California
|
-$9.36M |
| 3 |
Morgan Stanley
New York
|
-$7.27M |
| 4 |
TCM
Trybe Capital Management
Greenwich,
Connecticut
|
-$3.29M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.91M |
